Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. Th…
Biotechnology
US, San Diego [HQ]
Strategy & Leadership
All directors and officers of Sorrento Therapeutics, Inc. are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Each datapoint refers the most recent appearance of the corresponding person.
Officers & BofD Beta
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Total Compensation
Shows the total compensation per mentioned executive and board director.Each datapoint refers the most recent appearance of the corresponding person.
- No data, only available if we have DEF 14A compensations in place -
Officers
| Name & Position | Research | Last Appearance | ||
|---|---|---|---|---|
|
Ji Henry
President, CEO and Chairman of the Board of Directors
Also inside the BofD
|
03/20/23 [Form 4]
|
|||
|
Czerepak Elizabeth
EVP & Chief Financial Officer
|
05/20/22 [Form 4]
|
|||
|
Asghar Najjam
Chief Financial Officer
|
03/17/21 [Form 4]
|
|||
|
Shao Jiong
Chief Financial Officer
|
06/15/20 [Form 4]
|
|||
Board of Directors (BofD)
| Name & Position | Research | Last Appearance | ||
|---|---|---|---|---|
|
Janda Kim
Director
|
02/06/23 [Form 5]
|
|||
|
Reilly Tammy
Director
|
05/20/22 [Form 4]
|
|||
|
Smith Robin L
Director
|
09/03/21 [Form 4]
|
|||
|
Wu Yue Alexander
Director
|
08/30/21 [Form 4]
|
|||
|
Shah Jaisim
Director
|
08/30/21 [Form 4]
|
|||
|
Lemus David
Director
|
08/30/21 [Form 4]
|
|||
|
Followwill Dorman
Director
|
08/30/21 [Form 4]
|
|||
|
Lee Edgar
Director
|
06/15/20 [Form 4]
|
|||